{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:40:41Z","timestamp":1753890041641,"version":"3.41.2"},"reference-count":114,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,26]]},"DOI":"10.31744\/einstein_journal\/2025rw0753","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:05:24Z","timestamp":1740751524000},"source":"Crossref","is-referenced-by-count":0,"title":["Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis with trial sequential analysis"],"prefix":"10.31744","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5145-8869","authenticated-orcid":false,"given":"Thiago","family":"Gebrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0203-5758","authenticated-orcid":false,"given":"J\u00falia Pinho","family":"Neodini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5228-2033","authenticated-orcid":false,"given":"Andr\u00e9 Felix","family":"Gentil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3054-5661","authenticated-orcid":false,"given":"Eduardo Carvalhal","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3497-2206","authenticated-orcid":false,"given":"Mario","family":"Lenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-9378","authenticated-orcid":false,"given":"Arthur Werner","family":"Poetscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"issue":"7578","key":"key20250228140359_B1","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/nature16035","article-title":"Global neurotrauma research challenges and opportunities","volume":"527","author":"Rubiano","year":"2015","unstructured":"1. Rubiano AM, Carney N, Chesnut R, Puyana JC. Global neurotrauma research challenges and opportunities. Nature. 2015;527(7578):S193-7.","journal-title":"Nature"},{"issue":"10159","key":"key20250228140359_B2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"2. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-1858. Erratum in: Lancet. 2019;393(10190):e44.","journal-title":"Lancet"},{"issue":"46","key":"key20250228140359_B3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.15585\/mmwr.mm6846a2","article-title":"Traumatic brain injury-related deaths by race\/ethnicity, sex, intent, and mechanism of injury - United States, 2000-2017","volume":"68","author":"Daugherty","year":"2019","unstructured":"3. Daugherty J, Waltzman D, Sarmiento K, Xu L. Traumatic brain injury-related deaths by race\/ethnicity, sex, intent, and mechanism of injury - United States, 2000-2017. MMWR Morb Mortal Wkly Rep. 2019;68(46):1050-6.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"key20250228140359_B4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.apmr.2020.04.001","article-title":"A systematic review of the incidence, prevalence, costs, and activity and work limitations of amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury in the United States: a 2019 update","volume":"102","author":"Lo","year":"2021","unstructured":"4. Lo J, Chan L, Flynn S. A systematic review of the incidence, prevalence, costs, and activity and work limitations of amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury in the United States: a 2019 update. Arch Phys Med Rehabil. 2021;102(1):115-31.","journal-title":"Arch Phys Med Rehabil"},{"journal-title":"Morbidade hospitalar do SUS - por local de interna\u00e7\u00e3o - Brasil","author":"Brasil","key":"key20250228140359_B5","unstructured":"5. Brasil. Minist\u00e9rio da Sa\u00fade. Departamento de Inform\u00e1tica do SUS (DATASUS). Morbidade hospitalar do SUS - por local de interna\u00e7\u00e3o - Brasil. Bras\u00edlia (DF): DATASUS; s.d. [citado 2022 Jul 30]. Dispon\u00edvel em: http:\/\/tabnet.datasus.gov.br\/cgi\/tabcgi.exe?sih\/cnv\/nibr.def"},{"journal-title":"Procedimentos hospitalares do SUS - por local de interna\u00e7\u00e3o - Brasil","author":"Brasil","key":"key20250228140359_B6","unstructured":"6. Brasil. Minist\u00e9rio da Sa\u00fade. Departamento de Inform\u00e1tica do SUS (DATASUS). Procedimentos hospitalares do SUS - por local de interna\u00e7\u00e3o - Brasil. Bras\u00edlia (DF): DATASUS; s.d. [citado 2022 Jul 30]. Dispon\u00edvel em: http:\/\/tabnet.datasus.gov.br\/cgi\/tabcgi.exe?sih\/cnv\/qibr.def"},{"key":"key20250228140359_B7","author":"Ferring Pharmaceuticals Inc","year":"2016","unstructured":"7. Ferring Pharmaceuticals Inc. Lysteda\u2122 (tranexamic acid, USP) tablets. Parsippany: Ferring Pharmaceuticals Inc.; 2016 [cited 2020 Oct 10]. Available from: http:\/\/www.ferringusa.com\/wp-content\/uploads\/2016\/07\/LystedaPI_3.2016.pdf","journal-title":"Lysteda\u2122 (tranexamic acid, USP) tablets"},{"key":"key20250228140359_B8","author":"Exela Pharma Sciences LLC","year":"2019","unstructured":"8. Exela Pharma Sciences LLC. Tranexamic acid in sodium chloride- tranexamic acid injection solution. Lenoir: Exela Pharma Sciences LLC; 2019 [cited 2020 Oct 10]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=db36ddf2-4ac5-47ac-bdce-e3fa6983073e","journal-title":"Tranexamic acid in sodium chloride- tranexamic acid injection solution"},{"key":"key20250228140359_B9","volume-title":"As bases farmacol\u00f3gicas da terap\u00eautica de Goodman & Gilman","author":"Hogg","year":"2019","unstructured":"9. Hogg K, Weitz J. Coagula\u00e7\u00e3o sangu\u00ednea e f\u00e1rmacos anticoagulantes, fibrinol\u00edticos e antiplaquet\u00e1rios. In: Brunton LL, Hilal-Dandan R, Knollman B, organizadores. As bases farmacol\u00f3gicas da terap\u00eautica de Goodman & Gilman. 13a ed. Porto Alegre: AMGH; 2019, p. 737.","edition":"13a"},{"journal-title":"Monografia sobre drogas: tranexamic acid","year":"2023","key":"key20250228140359_B10","unstructured":"10. Monografia sobre drogas: tranexamic acid. Amsterdam: ClinicalKey; c2023 [citado 2023 Jan 16]. Dispon\u00edvel em: https:\/\/www.clinicalkey.com\/#!\/content\/drug_monograph\/6-s2.0-1591"},{"issue":"1","key":"key20250228140359_B11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccc.2016.08.004","article-title":"Tranexamic acid update in trauma","volume":"33","author":"Ramirez","year":"2017","unstructured":"11. Ramirez RJ, Spinella PC, Bochicchio GV. Tranexamic acid update in trauma. Crit Care Clin. 2017;33(1):85-99.","journal-title":"Crit Care Clin"},{"issue":"2","key":"key20250228140359_B12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archsurg.2011.287","article-title":"Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study","volume":"147","author":"Morrison","year":"2012","unstructured":"12. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012;147(2):113-9.","journal-title":"Arch Surg"},{"issue":"2","key":"key20250228140359_B13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/SHK.0b013e318280409a","article-title":"Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities","volume":"39","author":"Pusateri","year":"2013","unstructured":"13. Pusateri AE, Weiskopf RB, Bebarta V, Butler F, Cestero RF, Chaudry IH, Deal V, Dorlac WC, Gerhardt RT, Given MB, Hansen DR, Hoots WK, Klein HG, Macdonald VW, Mattox KL, Michael RA, Mogford J, Montcalm-Smith EA, Niemeyer DM, Prusaczyk WK, Rappold JF, Rassmussen T, Rentas F, Ross J, Thompson C, Tucker LD; US DoD Hemorrhage and Resuscitation Research and Development Steering Committee. Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock. 2013;39(2):121-6. Review.","journal-title":"Shock"},{"issue":"6","key":"key20250228140359_B14","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-014-0685-8","article-title":"Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial","volume":"18","author":"Roberts","year":"2014","unstructured":"14. Roberts I, Prieto-Merino D, Manno D. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Crit Care. 2014;18(6):685.","journal-title":"Crit Care"},{"issue":"6","key":"key20250228140359_B15","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc6173","article-title":"Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case-control study followed by a randomized, double-blind controlled trial","volume":"11","author":"Jimenez","year":"2007","unstructured":"15. Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case-control study followed by a randomized, double-blind controlled trial. Crit Care. 2007;11(6):R117.","journal-title":"Crit Care"},{"issue":"6","key":"key20250228140359_B16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/TA.0b013e318292cc54","article-title":"Tranexamic acid in trauma: how should we use it?","volume":"74","author":"Napolitano","year":"2013","unstructured":"16. Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013;74(6):1575-86.","journal-title":"J Trauma Acute Care Surg"},{"issue":"10210","key":"key20250228140359_B17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events, and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","author":"CRASH-3 trial collaborators","year":"2019","unstructured":"17. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events, and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713-23.","journal-title":"Lancet"},{"issue":"2","key":"key20250228140359_B18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajem.2019.158499","article-title":"The efficacy of tranexamic acid for brain injury: A meta-analysis of randomized controlled trials","volume":"38","author":"Chen","year":"2020","unstructured":"18. Chen H, Chen M. The efficacy of tranexamic acid for brain injury: A meta-analysis of randomized controlled trials. Am J Emerg Med. 2020;38(2):364-70.","journal-title":"Am J Emerg Med"},{"key":"key20250228140359_B19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.wneu.2018.11.214","article-title":"Effect of tranexamic acid in patients with traumatic brain injury: a systematic review and meta-analysis","volume":"123","author":"Weng","year":"2019","unstructured":"19. Weng S, Wang W, Wei Q, Lan H, Su J, Xu Y. Effect of tranexamic acid in patients with traumatic brain injury: a systematic review and meta-analysis. World Neurosurg. 2019;123:128-35.","journal-title":"World Neurosurg"},{"issue":"5","key":"key20250228140359_B20","article-title":"Antifibrinolytic drugs for acute traumatic injury","author":"Ker","year":"2015","unstructured":"20. Ker K, Roberts I, Shakur H, Coats TJ. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2015;2015(5): CD004896.","journal-title":"Cochrane Database Syst Rev"},{"key":"key20250228140359_B21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004896.pub3","article-title":"Antifibrinolytic drugs for acute traumatic injury","volume":"12","author":"Roberts","year":"2012","unstructured":"21. Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2012;12:CD004896.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"key20250228140359_B22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1460408619842736","article-title":"Efficacy of tranexamic acid in traumatic brain injury: updated systematic review and meta-analysis","volume":"21","author":"Alhelaly","year":"2019","unstructured":"22. Alhelaly MM, Soliman AM, Khaled A, Ellotf H, Attia MM, Elmaraezy A. Efficacy of tranexamic acid in traumatic brain injury: updated systematic review and meta-analysis. Trauma. 2019;21(3):167-75.","journal-title":"Trauma"},{"issue":"12","key":"key20250228140359_B23","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ajem.2014.09.023","article-title":"Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis","volume":"32","author":"Zehtabchi","year":"2014","unstructured":"23. Zehtabchi S, Abdel Baki SG, Falzon L, Nishijima DK. Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis. Am J Emerg Med. 2014;32(12):1503-9. Review.","journal-title":"Am J Emerg Med"},{"key":"key20250228140359_B24","doi-asserted-by":"crossref","DOI":"10.1186\/s40560-020-00460-5","article-title":"Efficacy and safety of tranexamic acid administration in traumatic brain injury patients: a systematic review and meta-analysis","volume":"8","author":"Yokobori","year":"2020","unstructured":"24. Yokobori S, Yatabe T, Kondo Y, Kinoshita K; Japan Resuscitation Council (JRC) Neuroresuscitation Task Force and the Guidelines Editorial Committee. Efficacy and safety of tranexamic acid administration in traumatic brain injury patients: a systematic review and meta-analysis. J Intensive Care. 2020;8:46. Review.","journal-title":"J Intensive Care"},{"issue":"1","key":"key20250228140359_B25","doi-asserted-by":"crossref","DOI":"10.1186\/s41016-020-00196-z","article-title":"The effect of tranexamic acid in patients with TBI: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Du","year":"2020","unstructured":"25. Du CN, Liu BX, Ma QF, Yang MF. The effect of tranexamic acid in patients with TBI: a systematic review and meta-analysis of randomized controlled trials. Chin Neurosurg J. 2020;6(1):14. Review.","journal-title":"Chin Neurosurg J"},{"issue":"1","key":"key20250228140359_B26","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-020-01694-4","article-title":"Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury - meta-analysis of randomized controlled trials","volume":"20","author":"July","year":"2020","unstructured":"26. July J, Pranata R. Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury - meta-analysis of randomized controlled trials. BMC Neurol. 2020;20(1):119.","journal-title":"BMC Neurol"},{"issue":"4","key":"key20250228140359_B27","article-title":"Haemostatic therapies for acute spontaneous intracerebral haemorrhage","volume":"4","author":"Al-Shahi Salman","year":"2018","unstructured":"27. Al-Shahi Salman R, Law ZK, Bath PM, Steiner T, Sprigg N. Haemostatic therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev. 2018;4(4):CD005951.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"key20250228140359_B28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004896.pub2","article-title":"Antifibrinolytic drugs for acute traumatic injury","author":"Coats","year":"2004","unstructured":"28. Coats T, Roberts I, Shakur H. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2004;(4):CD004896.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"key20250228140359_B29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105436","article-title":"Tranexamic acid inhibits hematoma expansion in intracerebral hemorrhage and traumatic brain injury. Does blood pressure play a potential role? A meta-analysis from randmized controlled trials","volume":"30","author":"Gao","year":"2021","unstructured":"29. Gao B, Xue T, Rong X, Yang Y, Wang Z, Chen Z, et al. Tranexamic acid inhibits hematoma expansion in intracerebral hemorrhage and traumatic brain injury. Does blood pressure play a potential role? A meta-analysis from randmized controlled trials. J Stroke Cerebrovasc Dis. 2021;30(1):105436.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10116","key":"key20250228140359_B30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","article-title":"Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients","volume":"391","author":"Gayet-Ageron","year":"2018","unstructured":"30. Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018;391(10116):125-32.","journal-title":"Lancet"},{"issue":"4","key":"key20250228140359_B31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-019-00608-4","article-title":"Tranexamic acid in cerebral hemorrhage: a meta-analysis and systematic review","volume":"33","author":"Hu","year":"2019","unstructured":"31. Hu W, Xin Y, Chen X, Song Z, He Z, Zhao Y. Tranexamic acid in cerebral hemorrhage: a meta-analysis and systematic review. CNS Drugs. 2019;33(4):327-36.","journal-title":"CNS Drugs"},{"key":"key20250228140359_B32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clineuro.2018.06.017","article-title":"Influence of tranexamic acid on cerebral hemorrhage: A meta-analysis of randomized controlled trials","volume":"171","author":"Huang","year":"2018","unstructured":"32. Huang B, Xu Q, Ye R, Xu J. Influence of tranexamic acid on cerebral hemorrhage: A meta-analysis of randomized controlled trials. Clin Neurol Neurosurg. 2018;171:174-8.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"key20250228140359_B33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00134-020-06279-w","article-title":"Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Lawati","year":"2021","unstructured":"33. Lawati KA, Sharif S, Maqbali SA, Rimawi HA, Petrosoniak A, Belley-Cote EP, et al. Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials. Intensive Care Med. 2021;47(1):14-27.","journal-title":"Intensive Care Med"},{"issue":"1","key":"key20250228140359_B34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007877.pub2","article-title":"Haemostatic drugs for traumatic brain injury","author":"Perel","year":"2010","unstructured":"34. Perel P, Roberts I, Shakur H, Thinkhamrop B, Phuenpathom N, Yutthakasemsunt S. Haemostatic drugs for traumatic brain injury. Cochrane Database Syst Rev. 2010;(1):CD007877.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"key20250228140359_B35","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","unstructured":"35. Wetterslev J, Jakobsen JC, Gluud C. Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):39.","journal-title":"BMC Med Res Methodol"},{"key":"key20250228140359_B36","author":"Thorlund","year":"2017","unstructured":"36. Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). Copenhagen: Copenhagen Trial Unit; 2017 [cited 2020 Oct 10]. Available from https:\/\/www.ctu.dk\/tsa\/files\/TSA_manual.pdf","journal-title":"User manual for Trial Sequential Analysis (TSA)"},{"issue":"7","key":"key20250228140359_B37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","unstructured":"37. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"key20250228140359_B38","volume-title":"Use of tranexamic acid in head injury: a sistematic revision and meta-analysis with trial sequential analysis [CRD42021221949]","author":"Poetscher","year":"2021","unstructured":"38. Poetscher A, Garcia T, Gentil A, Ribas E, Lenza M. Use of tranexamic acid in head injury: a sistematic revision and meta-analysis with trial sequential analysis [CRD42021221949]. York: Prospero: International prospective register of systematic reviews; 2021 [cited 2023 Jan 21]. Available from: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021221949"},{"key":"key20250228140359_B39","author":"Higgins","year":"2022","unstructured":"39. Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). London: Cochrane; 2022 [cited 2023 Jan 21]. Available from www.training.cochrane.org\/handbook","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022)"},{"key":"key20250228140359_B40","author":"Higgins","year":"2021","unstructured":"40. Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). London: Cochrane; 2021 [cited 2023 Jan 21]. Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.2","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021)"},{"key":"key20250228140359_B41","author":"Higgins","year":"2020","unstructured":"41. Higgins J, Thomas P, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). London: Cochrane; 2020 [cited 2023 Jan 21]. Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.1","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020)"},{"issue":"71","key":"key20250228140359_B42","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","unstructured":"42. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71):n71.","journal-title":"BMJ"},{"issue":"160","key":"key20250228140359_B43","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","unstructured":"43. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372(160):n160.","journal-title":"BMJ"},{"key":"key20250228140359_B44","author":"PRISMA 2020 Checklist","year":"2020","unstructured":"44. PRISMA 2020 Checklist. s.l.: PRISMA; 2020 [cited 2023 Jan 21]. Available from: https:\/\/www.prisma-statement.org\/documents\/PRISMA_2020_checklist.pdf","journal-title":"PRISMA"},{"key":"key20250228140359_B45","author":"PRISMA 2020 for Abstracts Checklist","year":"2020","unstructured":"45. PRISMA 2020 for Abstracts Checklist. s.l.: PRISMA; 2020 [cited 2023 Jan 21]. Available from: https:\/\/www.prisma-statement.org\/documents\/PRISMA_2020_abstract_checklist.pdf","journal-title":"s.l.: PRISMA"},{"key":"key20250228140359_B46","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.1 (updated september 2020)","author":"Higgins","year":"2020","unstructured":"46. Higgins J, Savovic J, Page M, Elbers R, Sterne J. Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, editors, et al Cochrane handbook for systematic reviews of interventions version 6.1 (updated september 2020). London: Cochrane; 2020 [cited 2020 Sep 14]. Available from http:\/\/www.training.cochrane.org\/handbook"},{"issue":"7650","key":"key20250228140359_B47","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","unstructured":"47. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6.","journal-title":"BMJ"},{"issue":"1","key":"key20250228140359_B48","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","unstructured":"48. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9(1):86.","journal-title":"BMC Med Res Methodol"},{"key":"key20250228140359_B49","author":"Rayyan","year":"2022","unstructured":"49. Rayyan. Cambridge: Rayyan Systems Inc.; c2022 [cited 2023 Jan 21]. Available from: rayyan.ai.","journal-title":"Cambridge: Rayyan Systems Inc."},{"issue":"1","key":"key20250228140359_B50","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","unstructured":"50. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"journal-title":"PICO Portal: transforming research findings into decision-ready evidence with ease","year":"2023","key":"key20250228140359_B51","unstructured":"51. PICO Portal: transforming research findings into decision-ready evidence with ease. St Petersburg: PICO Portal, Inc.; c2023 [cited 2023 Jan 21]. Available from: https:\/\/picoportal.org\/"},{"journal-title":"Clarivate","author":"EndNote Web","key":"key20250228140359_B52","unstructured":"52. EndNote Web. Philadelphia (PA): Clarivate; s.d. [cited 2023 Jan 21]. Available from: https:\/\/www.myendnoteweb.com\/EndNoteWeb.html"},{"key":"key20250228140359_B53","author":"The Retraction Watch Database","year":"2018","unstructured":"53. The Retraction Watch Database. New York: The Center for Scientific Integrity; 2018 [cited 2023 Jan 21]. Available from: www.retractiondatabase.org","journal-title":"New York: The Center for Scientific Integrity"},{"key":"key20250228140359_B54","author":"R Core Team","year":"2021","unstructured":"54. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021 [cited 2023 Jan 21]. Available from: https:\/\/www.R-project.org","journal-title":"R: A language and environment for statistical computing"},{"issue":"4","key":"key20250228140359_B55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","unstructured":"55. Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153-60.","journal-title":"Evid Based Ment Health"},{"journal-title":"Copenhagen: Copenhagen Trial Unit","author":"Copenhagen Trial Unit","key":"key20250228140359_B56","unstructured":"56. Copenhagen Trial Unit. Centre for Clinical Intervention Research. Copenhagen: Copenhagen Trial Unit; s.d. [cited 2023 Jan 21]. Available from: ctu.dk\/tsa\/downloads\/"},{"key":"key20250228140359_B57","author":"GRADEpro GDT","year":"2022","unstructured":"57. GRADEpro GDT. GRADEpro Guideline Development Tool. Hamilton: McMaster University and Evidence Prime; 2022 [cited 2016 Jan 16]. Available from: https:\/\/www.gradepro.org\/","journal-title":"GRADEpro Guideline Development Tool"},{"key":"key20250228140359_B58","author":"Sch\u00fcnemann","year":"2013","unstructured":"58. Sch\u00fcnemann H, Brozek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. s.l.: The GRADE Working Group; 2013 [cited 2023 Jan 16]. Available from: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html","journal-title":"GRADE handbook for grading quality of evidence and strength of recommendations"},{"journal-title":"Mountain View: Google","author":"Google Tradutor","key":"key20250228140359_B59","unstructured":"59. Google Tradutor. Mountain View: Google; s.d. [citado 2023 Jan 21]. Available from: https:\/\/translate.google.com"},{"journal-title":"Cologne: DeepL SE; s.d","author":"Deep L Tradutor","key":"key20250228140359_B60","unstructured":"60. Deep L Tradutor. Cologne: DeepL SE; s.d. [citado 2023 Jan 21]. Available from: https:\/\/www.deepl.com\/translator"},{"journal-title":"s.l.: Qhanzi; s.d","author":"Qhanzi","key":"key20250228140359_B61","unstructured":"61. Qhanzi. s.l.: Qhanzi; s.d. [cited 2023 Jan 21]. Available from: https:\/\/www.qhanzi.com\/"},{"issue":"16","key":"key20250228140359_B62","article-title":"Error in Table","volume":"324","author":"Error in Table","year":"2020","unstructured":"62. Error in Table. Error in Table. JAMA. 2020;324(16):1683.","journal-title":"JAMA"},{"issue":"10210","key":"key20250228140359_B63","article-title":"Department of Error","volume":"394","author":"Department of Error","year":"2019","unstructured":"63. Department of Error. Department of Error. Lancet. 2019;394(10210):1712.","journal-title":"Lancet"},{"issue":"10245","key":"key20250228140359_B64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(20)30541-9","article-title":"Tranexamic acid for traumatic brain injury","volume":"396","author":"Solla","year":"2020","unstructured":"64. Solla DJ, Rubiano AM, Teixeira MJ, de Andrade AF, Paiva WS. Tranexamic acid for traumatic brain injury. Lancet. 2020;396(10245):162-3.","journal-title":"Lancet"},{"issue":"1","key":"key20250228140359_B65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00068-020-01424-y","article-title":"CRASH 3: a monumental effort with minimal gain","volume":"47","author":"Phadtare","year":"2021","unstructured":"65. Phadtare CV, Deora H, Sadashiva N. CRASH 3: a monumental effort with minimal gain. Eur J Trauma Emerg Surg. 2021;47(1):269-71.","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"6","key":"key20250228140359_B66","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00134-019-05879-5","article-title":"Is tranexamic acid going to CRASH the management of traumatic brain injury?","volume":"46","author":"Taccone","year":"2020","unstructured":"66. Taccone FS, Citerio G, Stocchetti N. Is tranexamic acid going to CRASH the management of traumatic brain injury? Intensive Care Med. 2020;46(6):1261-3.","journal-title":"Intensive Care Med"},{"issue":"7","key":"key20250228140359_B67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM198408163110703","article-title":"Antifibrinolytic treatment in subarachnoid hemorrhage","volume":"311","author":"Vermeulen","year":"1984","unstructured":"67. Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984;311(7):432-7.","journal-title":"N Engl J Med"},{"issue":"2","key":"key20250228140359_B68","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.joms.2020.09.011","article-title":"Is preoperative administration of tranexamic acid effective on blood loss reduction in mandibular fracture surgeries? A triple-blind randomized clinical trial","volume":"79","author":"Khiabani","year":"2021","unstructured":"68. Khiabani K, Ahmadfar M, Labafchi A, Gosheh MR, Samieirad S. Is preoperative administration of tranexamic acid effective on blood loss reduction in mandibular fracture surgeries? A triple-blind randomized clinical trial. J Oral Maxillofac Surg. 2021;79(2):429.e1-7.","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"key20250228140359_B69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12975-020-00845-6","article-title":"Predictors and Outcomes of Neurological Deterioration in Intracerebral Hemorrhage: Results from the TICH-2 Randomized Controlled Trial","volume":"12","author":"Law","year":"2021","unstructured":"69. Law ZK, Dineen R, England TJ, Cala L, Mistri AK, Appleton JP, Ozturk S, Bereczki D, Ciccone A, Bath PM, Sprigg N; TICH-2 investigators. Predictors and Outcomes of Neurological Deterioration in Intracerebral Hemorrhage: Results from the TICH-2 Randomized Controlled Trial. Transl Stroke Res. 2021;12(2):275-83.","journal-title":"Transl Stroke Res"},{"key":"key20250228140359_B70","article-title":"Tranexamic acid for acute intracerebral haemorrhage (TICH): results of the first randomised controlled trial","volume":"7","author":"Sprigg","year":"2012","unstructured":"70. Sprigg N, Renton C, Kwong Y, Dineen R, Bath PM. Tranexamic acid for acute intracerebral haemorrhage (TICH): results of the first randomised controlled trial. Int J Stroke. 2012;7:7.","journal-title":"Int J Stroke"},{"journal-title":"Efficacy and safety of tranexamic acid for hyperacute intracerebral hemorrhage treatment: a multi-center randonmized controlled trial","year":"2021","key":"key20250228140359_B71","unstructured":"71. Efficacy and safety of tranexamic acid for hyperacute intracerebral hemorrhage treatment: a multi-center randonmized controlled trial. Chengdu: Chinese Clinical Trial Registry (ChiCTR); 2021. ChiCTR2100045022 [cited 2023 Jan 16]. Available from: https:\/\/www.chictr.org.cn\/showprojEN.html?proj=124135"},{"issue":"10135","key":"key20250228140359_B72","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","unstructured":"72. Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Christensen H, Ciccone A, Collins R, Czlonkowska A, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Krishnan K, Laska AC, Law ZK, Ozturk S, Pocock SJ, Roberts I, Robinson TG, Roffe C, Seiffge D, Scutt P, Thanabalan J, Werring D, Whynes D, Bath PM; TICH-2 Investigators. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391(10135):2107-15.","journal-title":"Lancet"},{"issue":"12","key":"key20250228140359_B73","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","article-title":"Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial","volume":"19","author":"Meretoja","year":"2020","unstructured":"73. Meretoja A, Yassi N, Wu TY, Churilov L, Sibolt G, Jeng JS, et al. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2020; 19(12):980-7.","journal-title":"Lancet Neurol"},{"issue":"5","key":"key20250228140359_B74","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.STR.10.5.519","article-title":"Tranexamic acid in subarachnoid hemorrhage. A double-blind study","volume":"10","author":"Kaste","year":"1979","unstructured":"74. Kaste M, Ramsay M. Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke. 1979;10(5):519-22.","journal-title":"Stroke"},{"journal-title":"The effect of tranexamic acid in reducing mortality and the need for blood transfusion in trauma patients with significant bleeding","year":"2016","key":"key20250228140359_B75","unstructured":"75. The effect of tranexamic acid in reducing mortality and the need for blood transfusion in trauma patients with significant bleeding. Tehran: Iranian Registry of Clinical Trials (IRCT); 2016. IRCT2016040816473N6 [cited 2023 Jan 16]. Available from: https:\/\/irct.behdasht.gov.ir\/trial\/15413"},{"journal-title":"Comparative of effectiveness prehospital received tranexamic acid on transmission blood volume on severe trauma patients","year":"2019","key":"key20250228140359_B76","unstructured":"76. Comparative of effectiveness prehospital received tranexamic acid on transmission blood volume on severe trauma patients. Tehran: Iranian Registry of Clinical Trials (IRCT); 2019. IRCT20140528017891N7 [cited 2023 Jan 16]. Available from: https:\/\/irct.behdasht.gov.ir\/trial\/40384"},{"journal-title":"Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign (TRAIGE)","year":"2015","key":"key20250228140359_B77","unstructured":"77. Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign (TRAIGE). s.l.: ClinicalTrials.gov; 2015. NCT02625948 [cited 2024 Apr 8]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02625948"},{"journal-title":"Effect of perioperative tranexamic acid on blood loss during management of maxillofacial trauma","year":"2020","key":"key20250228140359_B78","unstructured":"78. Effect of perioperative tranexamic acid on blood loss during management of maxillofacial trauma. s.l.: ClinicalTrials.gov; 2020. NCT04494126 [cited 2024 Apr 8]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04494126"},{"journal-title":"Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults","year":"2020","key":"key20250228140359_B79","unstructured":"79. Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults. s.l.: Cochrane Central Register of Controlled Trials (CENTRAL); 2020. NCT04521881 [cited 2024 Apr 8]. Available from: https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-02148020\/full"},{"issue":"9475","key":"key20250228140359_B80","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","article-title":"Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury outcomes at 6 months","volume":"365","author":"Edwards","year":"2005","unstructured":"80. Edwards P, Arango M, Balica L, Cottingham R, El-Sayed H, Farrell B, Fernandes J, Gogichaisvili T, Golden N, Hartzenberg B, Husain M, Ulloa MI, Jerbi Z, Khamis H, Komolafe E, Lalo\u00eb V, Lomas G, Ludwig S, Mazairac G, Mu\u00f1oz Sanch\u00e9z Mde L, Nasi L, Olldashi F, Plunkett P, Roberts I, Sandercock P, Shakur H, Soler C, Stocker R, Svoboda P, Trenkler S, Venkataramana NK, Wasserberg J, Yates D, Yutthakasemsunt S; CRASH trial collaborators. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury outcomes at 6 months. Lancet. 2005;365(9475):1957-9.","journal-title":"Lancet"},{"issue":"4","key":"key20250228140359_B81","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.annemergmed.2013.08.028","article-title":"Does the use of tranexamic acid improve trauma mortality?","volume":"63","author":"Harvey","year":"2014","unstructured":"81. Harvey V, Perrone J, Kim P. Does the use of tranexamic acid improve trauma mortality? Ann Emerg Med. 2014;63(4):460-2.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"key20250228140359_B82","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/TA.0000000000002022","article-title":"Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial","volume":"85","author":"Khan","year":"2018","unstructured":"82. Khan M, Jehan F, Bulger EM, O ' Keeffe T, Holcomb JB, Wade CE, Schreiber MA, Joseph B; PROPPR Study Group. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial. J Trauma Acute Care Surg. 2018;85(5):851-7.","journal-title":"J Trauma Acute Care Surg"},{"key":"key20250228140359_B83","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1111\/jth.12878","article-title":"Tranexamic acid in trauma: how should we use it?","volume":"13","author":"Roberts","year":"2015","unstructured":"83. Roberts I. Tranexamic acid in trauma: how should we use it? J Thromb Haemost. 2015;13 Suppl 1:S195-9.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"key20250228140359_B84","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ALN.0000000000004036","article-title":"Temporal transitions in fibrinolysis after trauma: adverse outcome is principally related to late hypofibrinolysis","volume":"136","author":"Rossetto","year":"2022","unstructured":"84. Rossetto A, Vulliamy P, Lee KM, Brohi K, Davenport R. Temporal transitions in fibrinolysis after trauma: adverse outcome is principally related to late hypofibrinolysis. Anesthesiology. 2022;136(1):148-61.","journal-title":"Anesthesiology"},{"issue":"1","key":"key20250228140359_B85","doi-asserted-by":"crossref","DOI":"10.1186\/1471-227X-9-15","article-title":"Intracranial bleeding in patients with traumatic brain injury: a prognostic study","volume":"9","author":"Perel","year":"2009","unstructured":"85. Perel P, Roberts I, Bouamra O, Woodford M, Mooney J, Lecky F. Intracranial bleeding in patients with traumatic brain injury: a prognostic study. BMC Emerg Med. 2009;9(1):15.","journal-title":"BMC Emerg Med"},{"key":"key20250228140359_B86","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/anae.12910","article-title":"The current place of tranexamic acid in the management of bleeding","volume":"70","author":"Hunt","year":"2015","unstructured":"86. Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia. 2015;70 Suppl 1:50-3.e18.","journal-title":"Anaesthesia"},{"issue":"9771","key":"key20250228140359_B87","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0140-6736(11)60396-6","article-title":"Tranexamic acid for trauma","volume":"377","author":"Gruen","year":"2011","unstructured":"87. Gruen RL, Mitra B. Tranexamic acid for trauma. Lancet. 2011;377(9771):1052-4.","journal-title":"Lancet"},{"issue":"3","key":"key20250228140359_B88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2014.11.009","article-title":"Tranexamic acid in brain injury: devil in the detail","volume":"33","author":"Zehtabchi","year":"2015","unstructured":"88. Zehtabchi S, Abdel Baki SG, Falzon L, Nishijima DK. Tranexamic acid in brain injury: devil in the detail. Am J Emerg Med. 2015;33(3):458.","journal-title":"Am J Emerg Med"},{"journal-title":"Pre-hospital administration of tranexamic acid for moderate and severe traumatic brain injury","year":"2015","key":"key20250228140359_B89","unstructured":"89. Pre-hospital administration of tranexamic acid for moderate and severe traumatic brain injury. s.l.: Cochrane Central Register of Controlled Trials (CENTRAL); 2015. NCT02645552 [cited 2023 Jan 16]. Available from: https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-01554849\/full"},{"issue":"3","key":"key20250228140359_B90","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1747493017694394","article-title":"Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: Rationale and design","volume":"12","author":"Liu","year":"2017","unstructured":"90. Liu L, Wang Y, Meng X, Li N, Tan Y, Nie X, Liu D, Zhao X; TRAIGE investigators. Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: Rationale and design. Int J Stroke. 2017;12(3):326-31.","journal-title":"Int J Stroke"},{"issue":"6","key":"key20250228140359_B91","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/TA.0000000000000242","article-title":"Do all trauma patients benefit from tranexamic acid?","volume":"76","author":"Valle","year":"2014","unstructured":"91. Valle EJ, Allen CJ, Van Haren RM, Jouria JM, Li H, Livingstone AS, et al. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg. 2014;76(6):1373-8.","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"key20250228140359_B92","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1007\/s00068-021-01848-0","article-title":"Efficacy and safety of the second in-hospital dose of tranexamic acid after receiving the prehospital dose: double-blind randomized controlled clinical trial in a level 1 trauma center","volume":"48","author":"El-Menyar","year":"2022","unstructured":"92. El-Menyar A, Ahmed K, Hakim S, Kanbar A, Mathradikkal S, Siddiqui T, et al. Efficacy and safety of the second in-hospital dose of tranexamic acid after receiving the prehospital dose: double-blind randomized controlled clinical trial in a level 1 trauma center. Eur J Trauma Emerg Surg. 2022;48(4):3089-99.","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"3","key":"key20250228140359_B93","first-page":"158","article-title":"The effect of a new potent antifibrinolytic agent, tranexamic acid","volume":"13","author":"Kobayashi","year":"1966","unstructured":"93. Kobayashi T, Sugiura J. The effect of a new potent antifibrinolytic agent, tranexamic acid. J Jpn Obstet Gynecol Soc. 1966;13(3):158-67.","journal-title":"J Jpn Obstet Gynecol Soc"},{"key":"key20250228140359_B94","author":"Mozafari","year":"2016","unstructured":"94. Mozafari J, Mousavinejad SM. Evaluation of therapeutic effect of tranexamic acid infusion on reducing blood loss during neurosurgery in traumatic brain injury patients with intraparenchymal hemorrhage. s.l.: Cochrane Central Register of Controlled Trials (CENTRAL) 2016 [cited 2023 Jan 27]. Available from: https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-02129393\/full","journal-title":"Evaluation of therapeutic effect of tranexamic acid infusion on reducing blood loss during neurosurgery in traumatic brain injury patients with intraparenchymal hemorrhage"},{"issue":"4","key":"key20250228140359_B95","doi-asserted-by":"crossref","first-page":"708","DOI":"10.21608\/ejhm.2021.152975","article-title":"The effect of tranexamic acid in patients with traumatic brain injury","volume":"82","author":"Atia","year":"2021","unstructured":"95. Atia SM, Nabeeh MM, Ahmed ME, Elsokary AE. The effect of tranexamic acid in patients with traumatic brain injury. Egypt J Hosp Med. 2021;82(4):708-13.","journal-title":"Egypt J Hosp Med"},{"issue":"4","key":"key20250228140359_B96","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00068-018-0974-z","article-title":"Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients","volume":"45","author":"Chakroun-Walha","year":"2019","unstructured":"96. Chakroun-Walha O, Samet A, Jerbi M, Nasri A, Talbi A, Kanoun H, et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients. Eur J Trauma Emerg Surg. 2019;45(4):719-26.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"key20250228140359_B97","article-title":"Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo-controlled trial (CRASH-2 Intracranial Bleeding Study)","volume":"343","author":"CRASH-2 Collaborators","year":"2011","unstructured":"97. CRASH-2 Collaborators, Intracranial Bleeding Study. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo-controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ. 2011;343:d3795.","journal-title":"BMJ"},{"issue":"4","key":"key20250228140359_B98","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/1574887114666190620112829","article-title":"Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial","volume":"14","author":"Ebrahimi","year":"2019","unstructured":"98. Ebrahimi P, Mozafari J, Ilkhchi RB, Hanafi MG, Mousavinejad M. Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial. Rev Recent Clin Trials. 2019;14(4):286-91.","journal-title":"Rev Recent Clin Trials"},{"key":"key20250228140359_B99","doi-asserted-by":"crossref","first-page":"e748","DOI":"10.1016\/j.wneu.2017.10.075","article-title":"Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury","volume":"109","author":"Fakharian","year":"2018","unstructured":"99. Fakharian E, Abedzadeh-Kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg. 2018;109:e748-53.","journal-title":"World Neurosurg"},{"issue":"1","key":"key20250228140359_B100","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.21608\/ejhm.2021.194045","article-title":"Effect of tranexamic acid in patients with traumatic brain injury","volume":"85","author":"Fathey","year":"2021","unstructured":"100. Fathey YI, Ghoneim HH, Afify NA, Aiad AE. Effect of tranexamic acid in patients with traumatic brain injury. Egypt J Hosp Med. 2021;85(1):3018-25.","journal-title":"Egypt J Hosp Med"},{"issue":"1","key":"key20250228140359_B101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","article-title":"The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial","volume":"20","author":"Jokar","year":"2017","unstructured":"101. Jokar A, Ahmadi K, Salehi T, Sharif-Alhoseini M, Rahimi-Movaghar V. The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial. Chin J Traumatol. 2017;20(1):49-51.","journal-title":"Chin J Traumatol"},{"key":"key20250228140359_B102","article-title":"The effect of intravenous tranexamic acid on preventing the progress of cerebral hemorrhage in patients with brain traumatic injuries compared to placebo: a randomized clinical trial","volume":"34","author":"Mojallal","year":"2020","unstructured":"102. Mojallal F, Nikooieh M, Hajimaghsoudi M, Baqherabadi M, Jafari M, Esmaeili A, et al. The effect of intravenous tranexamic acid on preventing the progress of cerebral hemorrhage in patients with brain traumatic injuries compared to placebo: a randomized clinical trial. Med J Islam Repub Iran. 2020;34:107.","journal-title":"Med J Islam Repub Iran"},{"issue":"1","key":"key20250228140359_B103","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1574887114666191118111826","article-title":"Intravenous tranexamic acid for brain contusion with intraparenchymal hemorrhage: randomized, double-blind, placebo-controlled trial","volume":"15","author":"Mousavinejad","year":"2020","unstructured":"103. Mousavinejad M, Mozafari J, Ilkhchi RB, Hanafi MG, Ebrahimi P. Intravenous tranexamic acid for brain contusion with intraparenchymal hemorrhage: randomized, double-blind, placebo-controlled trial. Rev Recent Clin Trials. 2020;15(1):70-5.","journal-title":"Rev Recent Clin Trials"},{"issue":"10","key":"key20250228140359_B104","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","author":"Rowell","year":"2020","unstructured":"104. Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, et al. Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA. 2020;324(10):961-74.","journal-title":"JAMA"},{"issue":"2","key":"key20250228140359_B105","first-page":"223","article-title":"Effect of intravenous tranexamic acid on intracerebral brain hemorrhage in traumatic brain injury","volume":"31","author":"Safari","year":"2021","unstructured":"105. Safari H, Farrahi P, Rasras S, Marandi HJ, Zeinali M. Effect of intravenous tranexamic acid on intracerebral brain hemorrhage in traumatic brain injury. Turk Neurosurg. 2021;31(2):223-7.","journal-title":"Turk Neurosurg"},{"issue":"381","key":"key20250228140359_B106","first-page":"478","article-title":"The effect of tranexamic acid on traumatic brain hematomas","volume":"34","author":"Tabesh","year":"2016","unstructured":"106. Tabesh H, Rezvani M, Salehi S. The effect of tranexamic acid on traumatic brain hematomas. J Isfahan Med School. 2016;34(381):478-83.","journal-title":"J Isfahan Med School"},{"issue":"1","key":"key20250228140359_B107","doi-asserted-by":"crossref","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial","volume":"13","author":"Yutthakasemsunt","year":"2013","unstructured":"107. Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, Thinkamrop B, Phuenpathom N, Lumbiganon P. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med. 2013;13(1):20.","journal-title":"BMC Emerg Med"},{"journal-title":"A multi-centre randomised, double-blind, placebo-controlled trial of pre-hospital treatment with tranexamic acid for severely injured patients at risk of acute traumatic coagulopathy","year":"2020","key":"key20250228140359_B108","unstructured":"108. A multi-centre randomised, double-blind, placebo-controlled trial of pre-hospital treatment with tranexamic acid for severely injured patients at risk of acute traumatic coagulopathy. Amsterdam: EU Clinical Trials Register; 2020. 2019-004118-33. [cited 2022 July 12]. Available from: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2019-004118-33\/DE"},{"journal-title":"Effect of Tranexamic Acid on conservative treatment of Epidural Hematoma in traumatic patients","year":"2014","key":"key20250228140359_B109","unstructured":"109. Effect of Tranexamic Acid on conservative treatment of Epidural Hematoma in traumatic patients. s.l.: International Clinical Trials Registry Platform (ICTRP); 2014. IRCT2014040915657N1. [cited 2022 July 16]. Available from: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=IRCT2014040915657N1"},{"journal-title":"Evaluating the effect of tranexamic acid on prevention of brain contusion, a clinical trial","year":"2019","key":"key20250228140359_B110","unstructured":"110. Evaluating the effect of tranexamic acid on prevention of brain contusion, a clinical trial. s.l.: International Clinical Trials Registry Platform (ICTRP); 2019. IRCT20181225042112N1. [cited 2022 July 16]. Available from: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20181225042112N1"},{"issue":"9734","key":"key20250228140359_B111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"CRASH-2 trial collaborators","year":"2010","unstructured":"111. CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mej\u00eda-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.","journal-title":"Lancet"},{"issue":"11","key":"key20250228140359_B112","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049839","article-title":"Effect of tranexamic acid on the prognosis of patients with traumatic brain injury undergoing craniotomy: study protocol for a randomised controlled trial","volume":"11","author":"Wu","year":"2021","unstructured":"112. Wu B, Lu Y, Yu Y, Yue H, Wang J, Chong Y, et al. Effect of tranexamic acid on the prognosis of patients with traumatic brain injury undergoing craniotomy: study protocol for a randomised controlled trial. BMJ Open. 2021;11(11):e049839.","journal-title":"BMJ Open"},{"key":"key20250228140359_B113","first-page":"S1","article-title":"Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis with trial sequential analysis (TSA)","volume":"19","author":"Poetscher","year":"2021","unstructured":"113. Poetscher AW, Garcia TG, Neodini JP, Gentil AF, Ribas ES, Lenza M. Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis with trial sequential analysis (TSA). einstein (S\u00e3o Paulo). 2021;19(Suppl 1):S1-S53.","journal-title":"einstein (S\u00e3o Paulo)"},{"key":"key20250228140359_B114","article-title":"Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis combined with trial sequential analysis","volume":"21","author":"Gebrin","year":"2023","unstructured":"114. Gebrin TG, Neodini JP, Gentil AF, Ribas ES, Lenza M, Poetscher AW. Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis combined with trial sequential analysis. einstein (S\u00e3o Paulo). 2023;21(Suppl 2):S6.","journal-title":"einstein (S\u00e3o Paulo)"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T14:05:54Z","timestamp":1740751554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/tranexamic-acid-in-the-management-of-traumatic-brain-injury-a-systematic-review-and-meta-analysis-with-trial-sequential-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":114,"alternative-id":["10.31744\/einstein_journal\/2025RW0753"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2025rw0753","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"type":"print","value":"1679-4508"},{"type":"electronic","value":"2317-6385"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"eRW0753"}}